IVF for Ovulation Disorders (PCOS / PMOS): When to Consider It
Key Takeaways
IVF is not the first step when ovulation is the only problem. For PMOS (formerly PCOS), letrozole is usually tried first. For hypothalamic amenorrhea, care starts by restoring energy balance. IVF is discussed if those steps do not lead to pregnancy. It is also discussed if treatment cannot safely produce one mature follicle, or if another fertility factor is present. If IVF is used, the protocol is adapted to lower the risk of ovarian hyperstimulation syndrome (OHSS).
Key evidence: ASRM: 2023 International Evidence-based Guideline for PCOS ASRM: Use of Exogenous Gonadotropins for Ovulation Induction (2020) ASRM: Prevention of moderate and severe OHSS (2023)
Dr. Aksoy’s Approach
Dr. Aksoy’s Approach: There is no universal “3-to-6-cycle rule” that automatically dictates moving to IVF. The decision depends on age, ovarian reserve, tubal patency, partner sperm quality, and how your body responded to previous ovulation induction. We do not manage anovulation with a stopwatch.
Understanding Ovulation Disorders
An ovulation disorder means eggs are released irregularly, or not at all. That is a frequent female-factor reason for delay in conceiving (ASRM gonadotrophin guidance 2020).
The usual groups are:
- PMOS, formerly PCOS. Polyendocrine metabolic ovarian syndrome is the same condition previously called polycystic ovary syndrome. ASRM endorsed the new name in May 2026 (ASRM 2026 nomenclature update). Many of the guidelines cited here still say PCOS. It can involve extra male-type hormones, metabolic change, and a high count of small follicles. See the PMOS / PCOS guide.
- Functional hypothalamic amenorrhea (FHA). Periods stop because the brain–pituitary–ovary axis slows. Low energy intake, stress, or heavy exercise often play a part.
- Other hormone problems. Thyroid disorders or high prolactin can also disturb ovulation.
PMOS and FHA do not respond to the same first medicines. That is why a label on its own does not pick the next step.
When IVF Becomes the Next Step
IVF is not first-line care when an ovulation disorder is the only finding.
For PMOS-related anovulation with no other major fertility factor, letrozole is the usual first medicine. Sometimes letrozole cannot be used, for example because off-label use is not permitted. Then WHO suggests clomiphene with metformin rather than clomiphene alone (WHO infertility guideline recommendations). If oral medicine fails, low-dose gonadotrophins — injectable follicle-stimulating hormone (FSH), with or without luteinising hormone (LH) — may be next. IVF can also be discussed at that point. Gonadotrophins raise the risk of twins and of ovarian over-response (2023 international PCOS guideline; ASRM gonadotrophin guidance 2020).
Ovarian drilling is another second-line option. It is a keyhole operation on the ovaries. The 2023 international guideline discusses laparoscopic ovarian surgery when clomiphene has not produced ovulation and no other fertility factor is present (2023 international PCOS guideline). After letrozole, or clomiphene with metformin, has failed, WHO suggests gonadotrophins rather than drilling (low certainty) (WHO infertility guideline recommendations). Gonadotrophins lead to more babies born alive than drilling, but also to more multiple pregnancies (2023 international PCOS guideline). See the FAQ on ovarian drilling below.
The 2023 international guideline says IVF could be offered in PCOS-related anovulation. This applies if first- or second-line ovulation induction has failed and there is no separate absolute reason for IVF (2023 international PCOS guideline). WHO suggests IVF rather than expectant management in PCOS (PMOS). This is for women whose letrozole, clomiphene with metformin, or gonadotrophins have not led to pregnancy. Expectant management means waiting and monitoring without medical treatment. The recommendation is conditional, and the evidence is of very low certainty (WHO infertility guideline recommendations).
For FHA, first-line care is restoring energy balance. Oral ovulation-induction medicines such as clomiphene or letrozole are unlikely to restart ovulation. When medicine is needed, gonadotrophins with both FSH and LH activity are used (ASRM gonadotrophin guidance 2020).
IVF may then be discussed in these situations:
| Situation | What it changes |
|---|---|
| Ovulation returns on treatment, but pregnancy does not | The delay may no longer be explained by ovulation alone |
| Blocked tubes, endometriosis, or a significant sperm problem | IVF can address more than ovulation; see blocked fallopian tubes |
| Age or a reduced ovarian reserve | Time may make a longer induction course a poorer fit |
| Treatment cannot safely produce a single mature follicle | Oral medicine or injections are not usable as planned. One mature follicle is the aim, because it keeps the chance of twins low |
Once IVF is chosen, elective single-embryo transfer can keep multiple pregnancy to a minimum in PCOS (PMOS). This means moving one embryo at a time (2023 international PCOS guideline). Ovarian stimulation in IVF and embryo transfer in IVF describe the cycle. Dosing and embryo freezing to lower OHSS risk are covered below.
OHSS Risk Mitigation and Safety
Women with a high follicle count, especially those with PMOS, often respond strongly and yield more eggs. They also face a higher risk of ovarian hyperstimulation syndrome (OHSS) — swollen, fluid-leaking ovaries after stimulation (ASRM OHSS prevention guideline 2023).
Modern protocols can lower that risk. No protocol removes it completely (ASRM OHSS prevention guideline 2023; 2023 international PCOS guideline):
- GnRH-antagonist protocols. These use a medicine that blocks gonadotrophin-releasing hormone (GnRH). They allow a GnRH-agonist trigger, the final injection that matures the eggs, instead of hCG (human chorionic gonadotrophin). That switch can reduce early, severe OHSS.
- Freezing all embryos. Deferring a fresh transfer avoids the extra hCG of an early pregnancy, a main driver of late OHSS. For more on freezing, see frozen embryos in IVF.
- Individual doses. Doses are set from ovarian reserve tests. One is AMH, a blood test that helps estimate how many eggs may be collected. The other is antral follicle count, the number of small follicles seen on ultrasound. Careful titration can limit recruitment of too many follicles.
Call your clinic promptly if you notice any of these warning signs: abdominal swelling or pain that keeps getting worse, nausea or vomiting that stops you drinking, shortness of breath, much less urine than usual, or rapid weight gain. They matter most during stimulation and in the first days after the final injection, and later if you become pregnant (ASRM OHSS prevention guideline 2023).
Evidence box: oocyte yield and OHSS in an older agonist-protocol cohort
Li and colleagues (2014) studied first IVF cycles from 2002 to 2009 at one centre, using a long GnRH-agonist protocol. There were three groups: 104 women with PCOS, 184 with polycystic ovaries but regular cycles, and 576 age-matched controls. Both PCOS and isolated polycystic ovaries gave a stronger ovarian response than in controls. Moderate to severe OHSS occurred in 11.5% of the PCOS group and 4.9% of controls. The 8.2% figure for isolated polycystic ovaries was not statistically different from controls. Fresh-cycle live-birth rates were similar, but the PCOS group had a higher miscarriage rate than the other two groups. Cumulative live births count the fresh transfer plus every frozen transfer from the same stimulation. That figure was higher with isolated polycystic ovaries (60.3%) than in controls (47.5%). The PCOS group (50.0%) was not significantly higher. These figures describe that centre, protocol, and era. They are not a personal chance, and they do not reflect current antagonist, agonist-trigger, and freeze-all practice (Li et al., 2014).
Shared Decision-Making and Realistic Expectations
When simpler treatment has not led to pregnancy, IVF is a reasonable next step to discuss. In practice, timing follows the factors in the table above.
Choosing IVF means weighing possible benefit against the physical, emotional, and financial load.
IVF bypasses the ovulatory problem in that cycle. It does not treat the underlying disorder. Hormone and metabolic care may still matter for long-term health and for pregnancy.
Related Reading
- PMOS (formerly PCOS): Diagnosis, Treatment and Fertility
- Letrozole for Fertility: Ovulation Induction and Frozen Embryo Transfer
- Ovarian Stimulation in IVF: Protocols, Timeline, and Safety
Frequently Asked Questions for Dr. Aksoy
Can you do IVF with irregular periods?
Yes, it can be done. Some of the patients who come to us for IVF already have irregular periods. We often see this in women with polycystic ovary syndrome (PCOS).
You do not need regular monthly periods, or to ovulate on your own, in order to have IVF. In IVF we stimulate the ovaries with medicine and produce egg development that way.
It still matters to understand why the cycles are irregular. PCOS, thyroid disease, high prolactin, or a reduced ovarian reserve can each be the cause, and they do not all change the plan in the same way. Sometimes we induce a bleed with medicine before starting. Sometimes we choose a different start from the hormone tests and the ultrasound.
In a frozen-embryo transfer, the lining can also be prepared with medicine in women whose periods are not regular.
So irregular periods are not a barrier to IVF. They are something we have to take into account when we plan treatment. Do not think that every irregular cycle needs IVF. If the only problem is irregular ovulation, pregnancy can also be achieved with simpler treatments.
Does IVF work for PCOS?
Yes. In women with PCOS, IVF can be a quite effective treatment. I do not, though, recommend IVF straight away for every woman I diagnose with PCOS.
For example, in a young woman whose tubes are open, whose partner’s sperm results are normal, but who is not ovulating regularly, I prefer to restore ovulation first with a medicine such as letrozole. IVF is then discussed if those treatments do not lead to pregnancy, or if there is another infertility problem.
One advantage in women with PCOS is that the ovaries often contain a large number of follicles. That also brings a risk: the ovaries can over-respond to stimulation medicine. So we have to choose the doses and the protocol carefully. When needed, we use methods that lower the risk of over-response, and we can freeze the embryos and leave the transfer for a later cycle.
I also make this point clearly: collecting a large number of eggs does not mean they are all of good quality, or that pregnancy will necessarily occur. The woman’s age, how the embryos develop, and other infertility factors affect the chance of success.
For me, the aim of IVF in PCOS is not to collect as many eggs as possible. It is to obtain, safely, enough mature eggs and embryos with pregnancy potential.
After ovarian drilling, how do you get pregnant?
Ovarian drilling is a laparoscopic procedure used in PCOS, particularly in some women in whom medicines have not produced ovulation. The aim is to treat specific points on the ovary in a controlled way, change the hormonal environment, and help spontaneous ovulation start.
We do not use it as a first option in PCOS care today. With letrozole, and with other ovulation treatments when needed, we can get a result in most patients without surgery.
In a woman who has already had drilling, I first look at whether periods and ovulation have settled into a regular pattern after the operation. If ovulation has started, the tubes are open, and the partner’s sperm results are normal, a period of trying for a natural pregnancy can be reasonable.
Regular periods do not necessarily mean that ovulation is happening, so we do progesterone testing or ultrasound monitoring when needed. If ovulation has not started, medicine can be considered again. If a few months pass without pregnancy, we decide the next step from the woman’s age, how long infertility has lasted, and the other findings.
One point I am particularly careful about is not rushing to repeat drilling. Surgery on the ovary can cause adhesions and loss of healthy ovarian tissue.
IVF is not required after drilling. If ovulation has not been restored, or if there are other causes of infertility as well, it is better to move to the appropriate treatment than to wait without a reason.
Sources
- World Health Organization. Guideline for the prevention, diagnosis and treatment of infertility. Geneva: World Health Organization; 2025.
- Mburu G, Santesso N, Brignardello-Petersen R, et al. Recommendations from the WHO guideline for the prevention, diagnosis, and treatment of infertility. Hum Reprod. 2026;41(1):25-38. doi:10.1093/humrep/deaf212.
- American Society for Reproductive Medicine. Use of exogenous gonadotropins for ovulation induction in anovulatory women: a committee opinion (2020).
- American Society for Reproductive Medicine. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.
- American Society for Reproductive Medicine. PCOS is now PMOS: Understanding the Name Change (2026).
- American Society for Reproductive Medicine. Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline (2023).
- Li HW, Lee VC, Lau EY, et al. Cumulative live-birth rate in women with polycystic ovary syndrome or isolated polycystic ovaries undergoing in-vitro fertilisation treatment. J Assist Reprod Genet. 2014;31(2):205-211.
Add as a Preferred Source on Google
You can add draksoyivf.com as one of your preferred health information sources on Google.
The content has been created by Dr. Senai Aksoy and medically approved.